Acetylsalicylic acid for venous thromboembolism prophylaxis comparative clinical effectiveness and guidelines
The purpose of this report is to examine the comparative clinical effectiveness of acetylsalicylic acid versus low-molecular-weight heparin or factor Xa inhibitors, and evidence-based guidelines regarding the use of acetylsalicylic acid or low-molecular-weight heparin, for venous thromboembolism pro...
Main Authors: | , |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
CADTH
November 14, 2017, 2017
|
Series: | CADTH rapid response report: summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The purpose of this report is to examine the comparative clinical effectiveness of acetylsalicylic acid versus low-molecular-weight heparin or factor Xa inhibitors, and evidence-based guidelines regarding the use of acetylsalicylic acid or low-molecular-weight heparin, for venous thromboembolism prophylaxis in patients undergoing total hip or knee replacement surgeries |
---|---|
Physical Description: | 1 PDF file (41 pages) illustration |